Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in Metastatic Papillary Renal Cell Carcinoma
NCT00601926Phase 2Terminated
- Start
- Feb 2008
- Primary completion
- Aug 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in papillary renal cell carcinoma (PRCC). Started Feb 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
papillary renal cell carcinoma (PRCC)
Beyond the preview
Go deeper on NCT00601926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601926.